AVS
Elizabeth Galle serves as the Vice President of Clinical Affairs at Amplitude Vascular Systems. Previous experience includes a position in Clinical Research at Boston Scientific and another role in Clinical Research at Fred Hutchinson Cancer Research Center. With a background in clinical research, Elizabeth Galle brings valuable expertise to their current leadership role in the vascular systems industry.
This person is not in any teams
This person is not in any offices
AVS
AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. They are redefining interventional therapy for severely calcified lesions with their Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device.